![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Response and survival benefit with chemoimmunotherapy in Epstein‐Barr virus‐positive diffuse large B‐cell lymphoma
Publisher: John Wiley & Sons Inc
E-ISSN: 1099-1069|36|1|93-97
ISSN: 0278-0232
Source: Hematological Oncology (Electronic), Vol.36, Iss.1, 2018-02, pp. : 93-97
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract